EUVIMEDEUVIMED entdecken
Crossref

Noninvasive Imaging of Immune Cell Activity in Myocardial Infarction Phases Using 99m Tc-HYNIC-mAb Kv1.3 SPECT/CT

Zhengyan Wang, Xiangming Song, Sixuan Cheng, Dawei Jiang iD, Danzhan Zheng, Xiaoli Lan iD, Kun Liu, Cheng Fan iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.4c00966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Zhengyan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Single Photon Emission Computed Tomography Computed Tomography, Antibodies, Monoclonal, Kv1.3 Potassium Channel. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Hubei Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myocardial infarction (MI) remains a leading cause of mortality worldwide, with inflammatory and reparative phases playing critical roles in disease progression. Currently, there is a pressing need for in vivo imaging techniques to monitor immune cell infiltration and inflammation activity during these phases. We developed a novel probe, 99mTc-HYNIC-mAbKv1.3, utilizing a monoclonal antibody that targets the voltage-gated potassium channel 1.3 (Kv1.3). This probe enables in vivo visualization of immune cells that express high levels of Kv1.3 proteins. In a murine MI model, SPECT/CT imaging with 99mTc-HYNIC-mAbKv1.3 demonstrated specific uptake in an infarcted myocardium during the inflammatory phase, reflecting immune cell infiltration and activity. During the reparative phase, the probe exhibited prolonged retention in the infarcted area, suggestive of ongoing immune cell proliferation. Immunofluorescence staining confirmed the probe's specificity. Biodistribution analysis indicated preferential accumulation in the infarcted myocardium and liver, consistent with SPECT/CT findings. Combined with [18F]FDG PET/CT, these modalities provided comprehensive insights into myocardial viability and inflammation. This study highlights the potential of 99mTc-HYNIC-mAbKv1.3 SPECT/CT as a noninvasive tool to monitor immune cell activity in different phases of MI, guide therapeutic interventions, and predict disease progression. Further translational studies are warranted to explore its clinical applicability in cardiac pathologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionSingle Photon Emission Computed Tomography Computed TomographyAntibodies, MonoclonalKv1.3 Potassium ChannelAnimalsMiceTissue DistributionDisease Models, AnimalMaleRadiopharmaceuticalsMyocardiumMice, Inbred C57BLInflammation

Stichwörter der Autor:innen

Kv1.3SPECT/CTinflammationmyocardial infarctionnuclear medicine

Substanzen

Antibodies, MonoclonalKv1.3 Potassium ChannelRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Hubei Engineering Research Center for Immunological Diagnosis and Therapy of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Hubei Key Laboratory of Molecular Imaging, Wuhan 430022, China.
  • Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

ORCID-Profile: Dawei Jiang, Xiaoli Lan, Cheng Fan

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Hubei Province
  • National Natural Science Foundation of China

Zitieren

APA

Wang, Z., Song, X., Cheng, S., Jiang, D., Zheng, D., Lan, X., Liu, K., & Fan, C. (2025). Noninvasive Imaging of Immune Cell Activity in Myocardial Infarction Phases Using 99m Tc-HYNIC-mAb Kv1.3 SPECT/CT. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00966

Vancouver

Wang Z, Song X, Cheng S, Jiang D, Zheng D, Lan X, et al. Noninvasive Imaging of Immune Cell Activity in Myocardial Infarction Phases Using 99m Tc-HYNIC-mAb Kv1.3 SPECT/CT. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c00966

BibTeX
@article{Wang2025,
  author = {Wang, Zhengyan and Song, Xiangming and Cheng, Sixuan and Jiang, Dawei and Zheng, Danzhan and Lan, Xiaoli and Liu, Kun and Fan, Cheng},
  title = {Noninvasive Imaging of Immune Cell Activity in Myocardial Infarction Phases Using 99m Tc-HYNIC-mAb Kv1.3 SPECT/CT},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.4c00966}
}
Kostenlos starten →